Sagent Pharmaceuticals Announces the Approval and Launch of Zoledronic Acid Injection 4 mg in a Plastic Vial

[at noodls] – SCHAUMBURG, Ill., March 5, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the approval and launch of Zoledronic Acid Injection 4 mg, the generic form of the bisphosphonate … more

View todays social media effects on SGNT

View the latest stocks trending across Twitter. Click to view dashboard

See who Sagent is hiring next, click here to view